Seres therapeutics to participate in 2025 j.p. morgan healthcare conference

Cambridge, mass., dec. 16, 2024 (globe newswire) -- seres therapeutics, inc. (nasdaq: mcrb), a leading live biotherapeutics company, today announced that management will participate in the 43rd annual j.p. morgan healthcare conference. eric shaff, president and chief executive officer, will present a corporate overview on january 16, 2025 at 7:30 a.m. pt.

mcrb Ratings Summary

mcrb Quant Ranking